LIF and oculocutaneous albinism: In this study, we examined whether LIF/LIFR signaling is essential for the progression of OCa and whether inhibiting LIF/LIFR signaling with the recently developed LIFR inhibitor, EC359 will have a therapeutic effect on OCa cells.